First patents for induced stem cells
A Californian biotechnology company has obtained the first US patent for developing a method to create stem cells from adult cells....
A cell with similar properties to an embryonic stem cell, but created in the laboratory by 'reprogramming' cells from adult tissues, such as skin cells.
A Californian biotechnology company has obtained the first US patent for developing a method to create stem cells from adult cells....
by Dr Jay Stone
The UK Gene Therapy Advisory Committee (GTAC) has given ReNeuron, a British biotech company, permission to begin the first ever clinical trial into using embryonic stem cells as a stroke treatment this year...
Researchers at the University of California, San Francisco, have discovered that microRNA (miRNA) play a key role in the switch in state between a stem cell and a mature, differentiated cell...
A research team at Stanford University School of Medicine has for the first time successfully transformed mouse skin cells directly into neurons. They achieved this by infecting the skin cells with a genetically modified virus that inserts three different genes into the cells' DNA...
Scientists at the University of California San Diego (UCSD), US, have developed a technique to transfer modified genes known to cause disease in humans into human embryonic stem cell (ES cell) lines. The modified ES cells behave like diseased cells and can be used to study human genetic diseases in the laboratory. The new technique provides an alternative approach to mouse 'knock out' models of disease....
With modern day medico-scientific technology advancing at an incredible pace, it is very easy for the layperson to become caught up in the technical language used by scientists and academics in their specialist field. Often, out of a lack of expertise, even the media misrepresent information, particularly in relation to research involving stem cells...
A commercial product claiming to be the first to make use of induced pluripotent stem cells (iPS cells) has been launched, albeit not a product that can be directly used on humans. Cellular Dynamics International (CDI), a biotech company based in Madison, Wisconsin, US, has recently announced that it has released human heart cells derived from iPS cells for commercial use. CDI intends its trademarked iCell Cardiomyocytes to be used by pharmaceutical companies to aid in the drug...
Regulators in the US have approved 13 new human embryonic stem cell (ES cell)lines - the first to be approved since President Obama lifted the restriction on stem cell research earlier this year in March. The 13 stem cell lines are the first the National Institutes of Health (NIH) has approved under the ethical guidelines that were unveiled in July; they are also the first new stem cells lines available to US scientists in almost a decade. It is hoped that the new lines, which are of
Researchers at the US Massachusetts Institute of Technology (MIT), lead by Professor Rudolf Jaenisch, have identified genetic pathways that can speed up the process of reprogramming mature adult cells into stem cells, known as induced pluripotent stem cells (iPS cells)....
Clinical studies presented at the annual meeting of the Society for Neuroscience in the United States have shown that stem cells may be used effectively in the treatment of eye disease and other retinal damage. As reported by Science Daily, in separate trials researchers demonstrated that fetal cells and retinal precursor cells derived from embryonic stem cells and also those developed using iPS (induced pluripotent stem) cells can help regenerate damaged areas of...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.